Overview of Faslodex.com
Faslodex.com was first analyzed by us on Jul 29, 2013.
We can see that the website is ONLINE.
The website has a good Google PageRank of 4.
The IP address of the server faslodex.com is hosted on is 164.109.33.26
and is based in Pittsburgh, United States
.
Websites Like Faslodex.com
Social Statistics
Facebook Stats |
Likes: |
2 |
Shares: |
8 |
Clicks: |
0 |
Comments: |
10 |
Website's On-page Analysis
HTML Tag Elements |
Paragraph: |
8 |
Strong: |
1 |
Tables: |
0 |
Lists: |
8 |
Total Images: |
9 |
Missing Alt: |
0 |
Internal Links: |
39 |
External Links: |
0 |
Forms: |
1 |
Fields: |
16 |
Page Headings |
H1 Tags: |
0 |
H2 Tags: |
4 |
H3 Tags: |
0 |
H4 Tags: |
1 |
H5 Tags: |
0 |
H6 Tags: |
0 |
Includes |
Iframe: |
0 |
Flash: |
0 |
CSS: |
2 |
Scripts: |
9 |
Page Statistics |
File Size: |
27.57 KB |
Word Count: |
401 |
Charset: |
UTF-8 |
Doctype: |
Yes |
Viewport: |
No |
Google Analytics: |
No |
Webmaster Tools: |
Yes |
Bing Webmaster Tools: |
No |
Meta elements are HTML elements used to provide structured metadata about a Web page.
We have listed below the meta elements we have extracted from faslodex.com.
Name |
Contents |
Title Tag: |
FASLODEX® (fulvestrant) Injection 500 mg | Metastatic Breast Cancer Treatment |
Description Tag: |
Official patient Web site for FASLODEX® (fulvestrant) Injection 500 mg, a treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer. |
Keywords Tag: |
FASLODEX, fulvestrant, injection, metastatic breast cancer treatment, hormone receptor-positive therapy |
robots |
noodp |
google-site-verification |
VWaAqYhzC8nhuY-VYWRecbJB1klNCG_UgIuzSjrVsWY |
Web Server Location
IP Address: |
164.109.33.26 |
Location: |
15122, Pittsburgh, Pennsylvania, United States |
Timezone: |
-04:00 |
|
Traffic Report
Alexa Global Rank: |
|
Compete: |
|
Quantcast: |
|
Keyword Analysis
We have attempted to list all keywords that have been repeated more than once and are topic related.
# |
Keyword |
Repeated |
Density |
1 | faslodex | 22 | 5.49% |
2 | breast | 12 | 2.99% |
3 | metastatic | 10 | 2.49% |
4 | treatment | 9 | 2.24% |
5 | injection | 8 | 2% |
6 | fulvestrant | 7 | 1.75% |
7 | hormone | 6 | 1.5% |
8 | faslodex® | 5 | 1.25% |
9 | patient | 3 | 0.75% |
10 | women | 2 | 0.5% |
11 | safety | 2 | 0.5% |
12 | prescribing | 2 | 0.5% |
13 | effects | 2 | 0.5% |
14 | pregnant | 2 | 0.5% |
15 | fda | 2 | 0.5% |
16 | receptor | 2 | 0.5% |
17 | positive | 2 | 0.5% |
18 | astrazeneca | 2 | 0.5% |
19 | doctor | 2 | 0.5% |
20 | cancer | 2 | 0.5% |
Website's HTTP Request
Name |
Content |
Date | Wed, 21 Aug 2013 09 |
---|
Server | Microsoft-IIS/6.0 |
---|
X-Powered-By | ASP.NET |
---|
X-AspNet-Version | 2.0.50727 |
---|
Cache-Control | private |
---|
Content-Type | text/html; charset=utf-8 |
---|
Content-Length | 28799 |
Add a widget to your website to gain more user confidence. Just copy & paste the html snippet into your website!